Monoamine Oxidase Inhibitors - MAOIs

Examples
Non selective - these drugs have been superseded by newer anti-depressants, but are still used occasionally MAOA MAOB
Indications
Treatment of refractory depression Parkinson's Disease (selegiline).
Contraindications
Contraindications Caution
Mechanism
Amine neurotransmitters (e.g. 5HT, catecholamines, dopamine) are broken down to inactive metabolites by the enzyme monoamine oxidase (MAO), of which two isoforms exist, in nerve terminals. MAOA is found principally in the gut and liver and MAOB is found in the brain. Monoamine oxidase inhibitors act to prevent the breakdown of amine neurotransmitters by irreversibly binding with the enzyme ( except moclobemide which binds reversibly).
Administration
All drugs are taken orally.

Specialist initiation only.
Adverse Reactions
Interactions
Patients should have a wash-out period of several weeks between stopping any antidepressants and starting MAOIs and vice versa.
Education
Patients should be warned that anti-depressants take 7-10 days to begin to work, and a month before their full benefit is seen. If effective, they should be continued for 3-12 months to avoid recurrence of symptoms upon discontinuation.

Warn patients these drugs can interfere with skilled motor tasks (e.g. driving).

Give patients taking MAOIs a warning card containing advice on how to avoid the tyramine interaction (they should avoid particular foods). They should also be warned of the signs of this reaction.
Pharmacokinetics
Monoamine oxidase inhibitors cause a rapid and sustained increase in the 5-HT, noradrenaline and dopamine content of the brain, 5-HT being affected most and dopamine least. Similar changes occur in peripheral tissues such as heart, liver and intestine, and increases in the plasma concentrations of these amines are also detectable.